17-alpha Hydroxyprogesterone caproate, commonly given to prevent recurrent preterm birth, is not effective for prevention and may increase the risk of gestational diabetes, according to a study in the American Journal of Obstetrics & Gynecology. Read more
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
